Moreover, using highly sensitive methods, studies have shown that T790M frequencies range from 40% to 79%, even in EGFR-TKI-naïve NSCLC patients harbouring EGFR-sensitive mutations16, 17, 18. Here, EGFR is linked to non-small cell lung carcinoma.